196 related articles for article (PubMed ID: 35427725)
1. Feiyanning downregulating CXCLs/CXCR2 axis to suppress TANs infiltration in the prevention of lung cancer metastasis.
Wu X; Xia J; Wang Z; Xu Z; Liu K; Fu X; Deng H
J Ethnopharmacol; 2022 Sep; 295():115277. PubMed ID: 35427725
[TBL] [Abstract][Full Text] [Related]
2. Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin.
Cheng Y; Mo F; Li Q; Han X; Shi H; Chen S; Wei Y; Wei X
Mol Cancer; 2021 Apr; 20(1):62. PubMed ID: 33814009
[TBL] [Abstract][Full Text] [Related]
3. Targeting both tumour-associated CXCR2
Nywening TM; Belt BA; Cullinan DR; Panni RZ; Han BJ; Sanford DE; Jacobs RC; Ye J; Patel AA; Gillanders WE; Fields RC; DeNardo DG; Hawkins WG; Goedegebuure P; Linehan DC
Gut; 2018 Jun; 67(6):1112-1123. PubMed ID: 29196437
[TBL] [Abstract][Full Text] [Related]
4. Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice.
Kong Q; Zhu H; Gong W; Deng X; Liu B; Dong J
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117183. PubMed ID: 37739106
[TBL] [Abstract][Full Text] [Related]
5. Acetyl-CoA metabolic accumulation promotes hepatocellular carcinoma metastasis via enhancing CXCL1-dependent infiltration of tumor-associated neutrophils.
Pan JJ; Xie SZ; Zheng X; Xu JF; Xu H; Yin RQ; Luo YL; Shen L; Chen ZR; Chen YR; Yu SZ; Lu L; Zhu WW; Lu M; Qin LX
Cancer Lett; 2024 Jun; 592():216903. PubMed ID: 38670307
[TBL] [Abstract][Full Text] [Related]
6. Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases.
Cheng Y; Ma XL; Wei YQ; Wei XW
Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):289-312. PubMed ID: 30703432
[TBL] [Abstract][Full Text] [Related]
7. The CXCLs-CXCR2 axis modulates the cross-communication between tumor-associated neutrophils and tumor cells in cervical cancer.
Ji HZ; Liu B; Ren M; Li S; Zheng JF; Liu TY; Yu HH; Sun Y
Expert Rev Clin Immunol; 2024 May; 20(5):559-569. PubMed ID: 38224014
[TBL] [Abstract][Full Text] [Related]
8. Triple-Negative Breast Cancer Cells Recruit Neutrophils by Secreting TGF-β and CXCR2 Ligands.
SenGupta S; Hein LE; Xu Y; Zhang J; Konwerski JR; Li Y; Johnson C; Cai D; Smith JL; Parent CA
Front Immunol; 2021; 12():659996. PubMed ID: 33912188
[TBL] [Abstract][Full Text] [Related]
9. Neutrophils in primary gastric tumors are correlated with neutrophil infiltration in tumor-draining lymph nodes and the systemic inflammatory response.
Hiramatsu S; Tanaka H; Nishimura J; Sakimura C; Tamura T; Toyokawa T; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Immunol; 2018 Apr; 19(1):13. PubMed ID: 29661142
[TBL] [Abstract][Full Text] [Related]
10. CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-β.
Jablonska J; Wu CF; Andzinski L; Leschner S; Weiss S
Int J Cancer; 2014 Mar; 134(6):1346-58. PubMed ID: 24154944
[TBL] [Abstract][Full Text] [Related]
11. CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer.
Li E; Yang X; Du Y; Wang G; Chan DW; Wu D; Xu P; Ni P; Xu D; Hu Y
Front Immunol; 2021; 12():667177. PubMed ID: 34025668
[TBL] [Abstract][Full Text] [Related]
12. Radiation-Induced Innate Neutrophil Response in Tumor Is Mediated by the CXCLs/CXCR2 Axis.
Zhang F; Mulvaney O; Salcedo E; Manna S; Zhu JZ; Wang T; Ahn C; Pop LM; Hannan R
Cancers (Basel); 2023 Dec; 15(23):. PubMed ID: 38067390
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
14. Pivotal Role for Cxcr2 in Regulating Tumor-Associated Neutrophil in Breast Cancer.
Timaxian C; Vogel CFA; Orcel C; Vetter D; Durochat C; Chinal C; NGuyen P; Aknin ML; Mercier-Nomé F; Davy M; Raymond-Letron I; Van TN; Diermeier SD; Godefroy A; Gary-Bobo M; Molina F; Balabanian K; Lazennec G
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070438
[TBL] [Abstract][Full Text] [Related]
15. Tumour-associated neutrophils secrete AGR2 to promote colorectal cancer metastasis via its receptor CD98hc-xCT.
Tian S; Chu Y; Hu J; Ding X; Liu Z; Fu D; Yuan Y; Deng Y; Wang G; Wang L; Wang Z
Gut; 2022 Dec; 71(12):2489-2501. PubMed ID: 35086885
[TBL] [Abstract][Full Text] [Related]
16. Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma.
Chung JY; Tang PC; Chan MK; Xue VW; Huang XR; Ng CS; Zhang D; Leung KT; Wong CK; Lee TL; Lam EW; Nikolic-Paterson DJ; To KF; Lan HY; Tang PM
Nat Commun; 2023 Mar; 14(1):1794. PubMed ID: 37002229
[TBL] [Abstract][Full Text] [Related]
17. Tumour-associated neutrophils orchestrate intratumoural IL-8-driven immune evasion through Jagged2 activation in ovarian cancer.
Yang M; Zhang G; Wang Y; He M; Xu Q; Lu J; Liu H; Xu C
Br J Cancer; 2020 Oct; 123(9):1404-1416. PubMed ID: 32778818
[TBL] [Abstract][Full Text] [Related]
18. Fyn tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates antiglioma immune responses.
Comba A; Dunn PJ; Argento AE; Kadiyala P; Ventosa M; Patel P; Zamler DB; Núñez FJ; Zhao L; Castro MG; Lowenstein PR
Neuro Oncol; 2020 Jun; 22(6):806-818. PubMed ID: 31950181
[TBL] [Abstract][Full Text] [Related]
19. M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer.
Hensler M; Kasikova L; Fiser K; Rakova J; Skapa P; Laco J; Lanickova T; Pecen L; Truxova I; Vosahlikova S; Moserova I; Praznovec I; Drochytek V; Rehackova M; Brtnicky T; Rob L; Benes V; Pistolic J; Sojka L; Ryska A; Sautes-Fridman C; Fridman WH; Galluzzi L; Spisek R; Fucikova J
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32819974
[TBL] [Abstract][Full Text] [Related]
20. Jinfukang inhibits lung cancer metastasis by regulating T cell receptors.
Luo B; Wang P; Tian J; Chu X; Lu X; Yang Y; Zhou Y; Li Y; Que Z
J Ethnopharmacol; 2024 Jan; 318(Pt A):116885. PubMed ID: 37422099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
